FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo ...
The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to ...
A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo Nordisk rolled out the first GLP-1 ...
Starting today, the Wegovy pill is available at more than 70,000 pharmacies, including CVS and Costco; telehealth providers ...
Denmark's Novo Nordisk will offer its 1.5 and 4 milligram Wegovy weightloss pills at $149 per month to self-paying patients ...
The oral version of the popular weight-loss injectable was approved by the Food and Drug Administration in December 2025.The ...
Novo Nordisk launched Ozempic in India on Friday—and the weight-loss drug, which is also sold as a diabetes treatment in some countries, will sell at a massive discount there compared with U.S. prices ...